Azra Raza
- Hematology top 0.02%
- Acute Myeloid Leukemia Research 206
- Chronic Myeloid Leukemia Treatments 46
- Hematopoietic Stem Cell Transplantation 32
- Multiple Myeloma Research and Treatments 27
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 37
- Chronic Lymphocytic Leukemia Research 30
- Molecular Biology top 1%
- Retinoids in leukemia and cellular processes 28
- Emergency Medicine top 0.5%
- Cancer Research top 2%
-
- Acute Lymphoblastic Leukemia research 43
- Co-authors
- Naomi GaliliBenjamin L. EbertHagop M. KantarjianHarvey D. PreislerJohn M. BennettAlan F. ListGuillermo Garcia‐ManeroKristen E. Stevenson
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Azra Raza
271 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 8.8k
- Genetics 3.6k
- Molecular Biology 5.5k
- Emergency Medicine 775
- Cancer Research 980
Countries citing papers authored by Azra Raza
This map shows the geographic impact of Azra Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azra Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azra Raza more than expected).
Fields of papers citing papers by Azra Raza
This network shows the impact of papers produced by Azra Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azra Raza. The network helps show where Azra Raza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Azra Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 36 | |
| 4 | 2019 | 92 | |
| 5 | 2017 | 4 | |
| 6 | 2015 | 150 | |
| 7 | 2012 | 312 | |
| 8 | 2010 | 2 | |
| 9 | 2009 | 92 | |
| 10 | 2008 | 111 | |
| 11 | 2007 | 17 | |
| 12 | Low incidence of JAK2 and FLT3 mutations in patients with chronic myelomonocytic leukemia (CMML) | 2006 | 1 |
| 13 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletionbreakdown → | 2006 | 893 |
| 14 | 2003 | 11 | |
| 15 | Myelodysplastic syndromes & secondary acute myelogenous leukemia : directions for the new millennium | 2001 | 4 |
| 16 | 1999 | 28 | |
| 17 | 1995 | 5 | |
| 18 | 1993 | 2 | |
| 19 | 1989 | 3 | |
| 20 | 1987 | 8 |
About Azra Raza
Azra Raza is a scholar working on Hematology, Genetics, Emergency Medicine, Orthopedics and Sports Medicine and Public Health, Environmental and Occupational Health, having authored 278 papers that have together received 12.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (206 papers), Chronic Myeloid Leukemia Treatments (46 papers), Acute Lymphoblastic Leukemia research (43 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers), Hematopoietic Stem Cell Transplantation (32 papers), Chronic Lymphocytic Leukemia Research (30 papers), Retinoids in leukemia and cellular processes (28 papers) and Multiple Myeloma Research and Treatments (27 papers). The work is most often cited by research in Hematology (8.8k citations), Genetics (3.6k citations), Molecular Biology (5.5k citations), Emergency Medicine (775 citations) and Cancer Research (980 citations). Azra Raza has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Naomi Galili, Benjamin L. Ebert, Hagop M. Kantarjian, Harvey D. Preisler, John M. Bennett, Alan F. List, Guillermo Garcia‐Manero, Kristen E. Stevenson, Omar Abdel‐Wahab and Rafael Bejar. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, British Journal of Haematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.